Pre-chronic kidney disease -- Serial creatinine tracks glomerular filtration rate decline above 60 mL/min

ABSTRACT

OBJECTIVES To allow primary clinicians to detect early decline in glomerular filtration rate (GFR) above 60 milliliters per minute (mL/min), before stage-three chronic kidney disease (CKD).

METHODS We re-examine a standard reference that found low tubular secretion of creatinine (TScr) at GFRs above 80 mL/min and suggested “observation of subtle changes in serum creatinine levels”. We explain why that method extends down to 60 mL/min. We summarize why estimated GFR (eGFR) is unreliable above 60 mL/min.

RESULTS Four patient cases show how serum creatinine (sCr) referenced to an individual’s historical maximum can suggest increased risk, triggering investigation to separate benign processes that alter sCr from true decline in GFR of prechronic kidney disease (preCKD).

CONCLUSIONS At GFRs above 60 mL/min, serial creatinine is more reliable than estimating equations and appears practical for ‘race-free’ clinical monitoring and early intervention.

• Download figure
• Open in new tab

STRENGTHS OF THIS STUDY

1. Includes serial creatinine proof-of-concept cases that show preCKD

2. Reviews ‘race-free’ properties that favor serial creatinine for early kidney disease

3. Addresses mathematical limitations of GFR estimating equations

4. Re-analyzes a 40-year-old standard reference that still influences research, showing its overlooked importance for early kidney diagnosis

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Brown University Health (formerly Lifespan) Human Reseach Protection Program waived ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes